Cancer Treatment News and Research

RSS

Women from ethnic minority backgrounds face more barriers to seeking medical help

The study published in Psycho-Oncology found that, in England, women from ethnic minority backgrounds were more likely to feel too embarrassed to talk to a GP (75-91%) than white women (8%).

11 Nov 2019

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia with the aim of developing research models that may help investigators better understand how CLL cells are influenced by new therapies.

11 Nov 2019

Affordable Care Act improves insurance coverage for people with HIV, cancer

A recent study reveals that, for people living with both HIV and cancer (PLWHC), implementation of the Patient Protection and Affordable Care Act (ACA) improved insurance coverage, both in states that expanded Medicaid coverage and those that did not.

11 Nov 2019

Mirada Medical announces series of installations of world’s first AI software for cancer treatment

Mirada Medical, a global leader in Artificial Intelligence software for the treatment of cancer, has announced today further global installations of DLCExpert, the world’s first commercially available AI-powered auto contouring software for cancer treatment planning and the only system with over one year of clinically proven use.

11 Nov 2019

Investigators use the power of computation to build better targeted drug therapy

Antibody drug conjugates (ADCs) -- cancer drugs that are designed to target and destroy cancerous tissue while leaving healthy cells intact -- represent a long sought-after advancement in cancer therapy.

8 Nov 2019

Hitachi and CLB in Lyon-France announce research collaboration to fight against cancer with AI

Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

8 Nov 2019

New model could predict response of HIV-infected individuals to cancer immunotherapy

A group of researchers at UPF and the Marchuk Institute of Numerical Mathematics in Moscow, Russia, have designed a mathematical model to predict the response of HIV-infected individuals to a type of cancer immunotherapy.

7 Nov 2019

Hitachi and CLB establish new research laboratory to improve diagnosis, treatment of cancer

Hitachi, Ltd. and Centre Leon Berard, a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

6 Nov 2019

Diminished taste function in cancer patients associated with reduced appetite

The simple pleasure of tasting and savoring food is "an important part of anyone's daily life," says University of Massachusetts Amherst sensory scientist Alissa Nolden.

6 Nov 2019

Gene-editing technique CRISPR trialed for first time as cancer treatment

The go-ahead has been given for the first trials using CRISPR as an alternative therapy for treating cancer.

6 Nov 2019

Chiral interactions could be leveraged to improve the performance of drug-delivery nanoparticles

MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling a trait of chemical structures known as chirality -- the "handedness" of the structure.

6 Nov 2019

Wake Forest Baptist receives $6 million to study non-pharmaceutical cancer pain management

For many people who've had cancer, severe pain can persist even after treatment ends.

5 Nov 2019

Researchers identify potential drug targets for glioblastoma

Researchers at Karolinska Institutet in Sweden have identified 10 tumor-specific potential drug targets for the brain tumor glioblastoma. The results are presented in the scientific journal Cell Reports.

5 Nov 2019

UK aims to lead with cutting-edge radiation therapy

The UK is all set to launch its run into the future as the undisputed leader in the field of personalized and effective radiation therapy. The proposal is undergirded by a whopping £56 million, which will be used to set up and fund advanced radiation therapy research by a new collaborative setup, Cancer Research UK RadNet, over five years. This is the largest sum ever invested by this organization into radiotherapy research.

4 Nov 2019

Facts about lung cancer and ways to reduce your risk

Lung cancer is the second most common cancer in both men and women in the United States. According to the American Cancer Society, about 13% of all new cancers are lung cancers. There will be an estimated 228,000 new cases of lung cancer this year, with more than 142,000 deaths. Moreover, the 5-year survival rate is less than 20%.

4 Nov 2019

Study describes a molecular strategy that helps prevent development of tumors in mice

The body's process for manufacturing fatty acids is regulated by the enzyme FASN. In normal cells, this is not a very active process - except occasionally in the liver and adipose tissue - since most of the fatty acids we need for cell maintenance are obtained from the diet.

4 Nov 2019

Study: Checkpoint inhibitor prolongs survival in patients with head and neck cancers

The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to a new global study led by Yale Cancer Center (YCC). The data was published today in the journal The Lancet.

1 Nov 2019

Kidney damage common in patients receiving immunotherapy for cancer, study finds

A new study indicates that kidney damage is fairly common in patients who take immunotherapy medications for treating cancer. The findings, which appear in an upcoming issue of CJASN, will be important for maintaining the kidney health of patients who are prescribed these drugs.

31 Oct 2019

Mount Sinai hosts Fourth Annual Prostate Cancer Research Gala

The Department of Urology at the Icahn School of Medicine at Mount Sinai will host its Fourth Annual Prostate Cancer Research Gala on Wednesday, November 6, at Cipriani 42nd Street.

31 Oct 2019

Optometrists reduce opioid prescription without increasing pain

Optometrists at the University of Michigan have introduced a new approach to prescribing opioids in an effort to help curb the nation’s opioid epidemic.

31 Oct 2019

Cancer Treatment News and Research

Women from ethnic minority backgrounds face more barriers to seeking medical help

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Affordable Care Act improves insurance coverage for people with HIV, cancer

Mirada Medical announces series of installations of world’s first AI software for cancer treatment

Investigators use the power of computation to build better targeted drug therapy

Hitachi and CLB in Lyon-France announce research collaboration to fight against cancer with AI

New model could predict response of HIV-infected individuals to cancer immunotherapy

Hitachi and CLB establish new research laboratory to improve diagnosis, treatment of cancer

Diminished taste function in cancer patients associated with reduced appetite

Gene-editing technique CRISPR trialed for first time as cancer treatment

Chiral interactions could be leveraged to improve the performance of drug-delivery nanoparticles

Wake Forest Baptist receives $6 million to study non-pharmaceutical cancer pain management

Researchers identify potential drug targets for glioblastoma

UK aims to lead with cutting-edge radiation therapy

Facts about lung cancer and ways to reduce your risk

Study describes a molecular strategy that helps prevent development of tumors in mice

Study: Checkpoint inhibitor prolongs survival in patients with head and neck cancers

Kidney damage common in patients receiving immunotherapy for cancer, study finds

Mount Sinai hosts Fourth Annual Prostate Cancer Research Gala

Optometrists reduce opioid prescription without increasing pain

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News